The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antitumor activity of tipifarnib and PI3K pathway inhibitors in HRAS-associated HNSCC.
 
Francis Burrows
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
 
Shivani Malik
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
 
Zhiyong Wang
No Relationships to Disclose
 
Stacia Chan
Employment - Kura Oncology
 
Silvio Gutkind
Leadership - Domain Therapeutics; Oncoceutics; Vividion Therapeutics
Honoraria - Domain Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - Domain Therapeutics; Oncoceutics; Vividion Therapeutics
Research Funding - Dracen; Kura Oncology; Mavupharma; Revolution Medicines
Travel, Accommodations, Expenses - Domain Therapeutics